Related Experiment Videos

Are there still limitations for the use of target-controlled infusion in children?

Brian J Anderson1, Bryan Hodkinson

  • 1Department of Anaesthesiology, University of Auckland, Auckland, New Zealand. briana@adhb.govt.nz

Current Opinion in Anaesthesiology
|April 14, 2010
PubMed

Insights

Target controlled infusion (TCI) devices offer benefits in pediatric anesthesia, but limited pharmacokinetic data and hardware issues hinder widespread use. Further research is needed for optimal pediatric TCI application.

Area of Science:

  • Anesthesiology
  • Pharmacokinetics
  • Pediatric Medicine

Background:

  • Target controlled infusion (TCI) offers advantages in pediatric anesthesia, including rapid drug action and reduced side effects.
  • Despite benefits, TCI use in children is not widespread due to several limitations.

Purpose of the Study:

  • To review the reasons limiting the widespread adoption of TCI in pediatric anesthesia.
  • To identify challenges in implementing TCI for pediatric patients.

Main Methods:

  • Literature review examining current TCI devices and their application in pediatric anesthesia.
  • Analysis of pharmacokinetic/pharmacodynamic data relevant to pediatric TCI.

Main Results:

  • Lack of integrated pharmacokinetic/pharmacodynamic models for pediatric TCI across age ranges.
  • Divergent pharmacokinetic parameter sets and limited validation studies for pediatric populations.
  • Need for neonate-specific algorithms for advanced monitoring and challenges with intravenous induction.

Conclusions:

  • Hardware limitations, insufficient pharmacokinetic/pharmacodynamic integration, and monitoring issues restrict TCI use in pediatrics.
  • While intravenous induction remains a challenge, TCI is increasingly used for maintenance anesthesia in children.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...